ReceptIVFity® is the first non-invasive vaginal microbiome test for assessing the probability of reproductive success in ICSI-IVF treatments. The test results indicate the likelihood of reproductive success, allowing patients to plan the embryo implantation time. It has a high specificity (97%) and predictive accuracy (94%).
ReceptIVFity® was created as a personalised test to:
ReceptIVFity® analyses the vaginal bacterial composition, allowing specialists to assess whether the conditions are optimal for embryo implantation prior to treatment. From this analysis, the predictive algorithm generates a high, medium or low score depending on the proportion of bacteria in the vagina. In HIGH microbiome profiles, the success rate (first cycle) of ICSI-IFV treatments increases from 30% to over 50%. And in HIGH and MEDIUM profiles, it increases to 41% on average.
Turnaround time: 10 working days from receipt of the sample.
Reference: IVF1001
Please remember to attach the Informed Consent Form to the sample, which you will find on the right..
